A Trial Using Double-Bolus THR-100 Versus Streptokinase

NCT01305226 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myocardial Infarction

Interventions

DRUG: THR-100
DRUG: Streptokinase

Sponsor

Bharat Biotech International Limited